Markets /Healthcare /CERO CERo Therapeutics Holdings, Inc. CERO Full chart Compare Add to watchlist Set alert Price alert · CERO Alert when the price is Price abovePrice below Price level Set alert All alert types 0.00 USD 0.00 (-1.23%) As ofNov 18, 2026, 2:29 PM EST 0.004 Day range 0.0041 0.003 52-week range 0.135 YTD -94.03%1 year -94.59% Overview Chart ChartPrice historyFinancials FinancialsValuation & healthEarnings EarningsDividends & splitsAnalysts News Ownership Options More ComparisonSignalsTrend ScoreDiscussionNotesPositionsAlerts News All sources Benzinga only 3 weeks ago benzinga.com SRX Global Says UC Davis Activated As Clinical Trial Site For CERTAIN-T, Ongoing Phase 1 Study Evaluating CER-1236 In Patients With Hematologic Malignancies Being Conducted By CERo Therapeutics UC Davis is the primary manufacturing site for CER-1236, site activation is expected to expand patient recruitment capacity and streamline treatment logisticsUpdate follows SRX’s previously announced…